i-SENS, Inc. engages in the development, manufacture, and sale of sensors and measuring instruments based on electrochemical and biosensor technologies in South Korea and internationally. The company offers blood glucose monitoring devices; measuring instruments and point-of-care diagnostic devices (POCT), biosensor technologies, diabetes care, acute care, and coagulation care devices; veterinary care devices; and IVD systems. It also provides SmartLog, diabetes management software for mobile and PC. The company was founded in 2000 and is headquartered in Seoul, South Korea.
Metrics to compare | 099190 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship099190PeersSector | |
|---|---|---|---|---|
P/E Ratio | 1,009.0x | 17.3x | −0.5x | |
PEG Ratio | 7.29 | 0.31 | 0.00 | |
Price/Book | 2.2x | 1.2x | 2.6x | |
Price / LTM Sales | 2.2x | 1.8x | 3.3x | |
Upside (Analyst Target) | 14.6% | 35.9% | 45.6% | |
Fair Value Upside | Unlock | 30.6% | 4.9% | Unlock |